Keywords
Insulin resistance
Diabetes
Treatment
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the association between Polycystic Ovary Syndrome (PCOS) with the development of insulin resistance (IR), including the types of treatments involved. Methods: This consists of an integrative literature review conducted in September 2024, using the National Library of Medicine and National Institutes of Health (PubMed) and Biblioteca Virtual de Saúde (BVS) databases. The descriptors used, based on the Descritores em Ciências da Saúde (DeCS), were “polycystic ovary syndrome” and “insulin resistance,” combined with the Boolean operator AND. Systematic reviews, meta-analyses, and literature reviews were excluded, and studies freely available, published between 2019 and 2024, were included. Results: This article was developed based on the analysis of 15 studies addressing the correlation between PCOS and insulin resistance, including the necessary interventions for these conditions. The findings are presented in Tables 1 and 2, which includes the authors and the main findings. Conclusions: Based on the analysis of the studies, it can be concluded that women with PCOS have a higher tendency of developing IR, and there are treatments that can attenuate these outcomes.
References
DIETZ DE LOOS A, et al. Metabolic health during a randomized controlled lifestyle intervention in women with PCOS. European Journal of Endocrinology, 2022; 186: 53-64.
FATIMA Q, et al. Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019; 13: 1957-1961.
FREEMAN AM, et al. Insulin Resistance. Nih.gov, 2023.
HESHMATI J, et al. Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. Phytomedicine, 2021; 80: 153395.
JABARPOUR M, et al. Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple-blind randomized clinical trial. Phytotherapy research: PTR, 2024; 38: 321-330.
LEJMAN-LARYSZ K, et al. Influence of vitamin D on the incidence of metabolic syndrome and hormonal balance in patients with polycystic ovary syndrome. Nutrients, 2023; 15: 2952.
LI X, et al. The risk factors of gestational diabetes mellitus in patients with polycystic ovary syndrome. Medicine, 2021; 100: 26521.
LIVADAS S, et al. Insulin resistance, androgens, and lipids are gradually improved in an age-dependent manner in lean women with polycystic ovary syndrome: insights from a large Caucasian cohort. Hormones, 2020; 19: 531-539.
MA R, et al. Short-term combined treatment with exenatide and metformin for overweight/ obese women with polycystic ovary syndrome. Chinese Medical Journal, 2021; 134: 2882-2889.
MAFFAZIOLI GDN, et al. Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil. International Journal of Gynecology & Obstetrics, 2020; 151: 383-391.
MORGANTE G, et al. Metformin doses and body mass index: clinical outcomes in insulin resistant polycystic ovary syndrome women. European review for medical and pharmacological sciences, 2020; 24: 8136-8142.
RONDANELLI M, et al. Berberine phospholipid is an effective insulin sensitizer and improves metabolic and hormonal disorders in women with polycystic ovary syndrome: A one-group pretest-post-test explanatory study. Nutrients, 2021; 13: 3665.
RYU K, et al. Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort Study. Fertility and Sterility, 2021; 115: 1569-1575.
SHAHMORADI S, et al. The effect of magnesium supplementation on insulin resistance and metabolic profiles in women with polycystic ovary syndrome: a randomized clinical trial. Biological Trace Element Research, 2023; 202: 941-946.
WEN Q, et al. Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial. Human Reproduction, 2021; 37: 542-552.
WHO. WORLD HEALTH ORGANIZATION. 2023. In: Polycystic ovary syndrome. Disponível em: https ://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome. Acesso em: 6 nov. 2024.